C-Rad AB (publ) (FRA:24C)

Germany · Delayed Price · Currency is EUR

2.725

-0.100 (-3.54%)

Last updated: Dec 5, 2025, 8:03 AM CET

-0.18% (1Y)

Market Cap	95.64M
Revenue (ttm)	41.39M
Net Income (ttm)	2.10M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	45.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	55
Open	2.725
Previous Close	2.825
Day's Range	2.725 - 2.725
52-Week Range	2.285 - 3.310
Beta	n/a
RSI	46.74
Earnings Date	Feb 12, 2026

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports pr... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 2004

Employees 99

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 24C

Full Company Profile

Financial Performance

In 2024, C-Rad AB's revenue was 469.00 million, an increase of 10.45% compared to the previous year's 424.62 million. Earnings were 56.45 million, an increase of 58.88%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.